Download PDF
Drug Res (Stuttg) 2023; 73(03): 156-163
DOI: 10.1055/a-1934-1806
Original Article

The efficacy of 2-formyl benzoic acid in reactivating diazinon inhibited murine cholinesterase

Humayun Farhat
1   Student Research Committee, Babol University of Medical Sciences, Babol, Iran
2   Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
3   Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran
,
Ebrahim Zabihi
2   Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
3   Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran
,
Fatemeh Alibabaei-Omran
1   Student Research Committee, Babol University of Medical Sciences, Babol, Iran
2   Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
3   Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran
,
Maryam Mohammadi-Khanaposhti
2   Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Oximes, as classical acetylcholinesterase (AChE) reactivators, have some pharmacokinetics/pharmacodynamics disadvantages. During the synthesis of non-oxime compounds, we encountered the compound 2-formylbenzoic acid (2-FBA) with promising in vitro and in vivo cholinesterase (ChE) reactivating properties in the acute exposure to diazinon (DZN). For in vitro experiments, the healthy mice serum and brain homogenate were freshly prepared and exposed to DZN (160 µg/mL). After 10 minutes, 2-FBA was added to the poisoned samples, and ChE activity was measured afterward. For the in vivo assay, the mice were poisoned with DZN subcutaneous (SC) injection (50 mg/kg), and after 1 hour, either 2-FBA or Pralidoxime (2-PAM) was injected intravenously (IV). After 3 h, ChE activity was measured in the serum and brain homogenate samples. The LD50 (IV) for 2-FBA in mice was measured as well. 2-FBA effectively reactivated the inhibited ChE in serum and brain homogenate samples in vitro. In the in vivo experiments, while 2-FBA could significantly reactivate the brain ChE even better than 2-PAM, they failed to reactivate the serum ChE by single IV injection. LD50 of 2-FBA was calculated to be 963 mg/kg. There were no general toxicity signs in any treatment groups. The in silico results support the potential ability of 2-FBA efficacy via possibly Witting reaction mechanism. Our findings indicate that 2-FBA seems to be a suitable non-oxime candidate for AChE reactivation with minimal side effects. Further toxicokinetic studies on this compound are strongly recommended to be performed before conducting the clinical trial in humans.

Keywords

Non-oxime - Diazinon - Cholinesterase activity - Pralidoxime - Organophosphate - LD50


Publication History

Received: 11 June 2022

Accepted: 29 August 2022

Article published online:
10 January 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Marrs TC.. Organophosphate poisoning 1993; 58: 51-66
    PubMedSearch in Google Scholar
  • 2 Dunn MA, Sidell FR.. Progress in Medical Defense Against Nerve Agents. 1989
    PubMedSearch in Google Scholar
  • 3 Watson A, Opresko D, Young RA, Hauschild V, King J, Bakshi K.. Organophosphate Nerve Agents 2015; 87-109
    PubMed
  • 4 Pita R, Domingo J.. The Use of Chemical Weapons in the Syrian Conflict 2014; 2: 391-402
    PubMedSearch in Google Scholar
  • 5 Achilles J. Pappano. Cholinoceptor-activating and cholinesteraseinhibiting drugs. Basic Clin. Pharmacol. 14th ed.McGraw-Hill Education; 2017: pp 121–137
  • 6 Stefanidou M, Athanaselis S, Spiliopoulou H.. Butyrylcholinesterase: biomarker for exposure to organophosphorus insecticides 2009; 39: 57-60
    PubMedSearch in Google Scholar
  • 7 Eddleston M, Buckley NA, Eyer P, Dawson AH.. Management of acute organophosphorus pesticide poisoning. 2008
    PubMedSearch in Google Scholar
  • 8 Millard CB, Kryger G, Ordentlich A, Greenblatt HM, Harel M, Raves ML. et al. Crystal structures of aged phosphonylated acetylcholinesterase: Nerve agent reaction products at the atomic level 1999; 38: 7032-7039
    PubMedSearch in Google Scholar
  • 9 John H, van der Schans MJ, Koller M, Spruit HET, Worek F, Thiermann H. et al. Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network. 2018
    PubMedSearch in Google Scholar
  • 10 Szegletes T, Mallender WD, Thomas PJ, Rosenberry TL.. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect 1999; 38: 122-133
    PubMedSearch in Google Scholar
  • 11 Yuantari MGC, Cornelis AM, Van Gestel NM, Van S, Widianarko B, Sunoko HR. et al. Knowledge, attitude, and practice of Indonesian farmers regarding the use of personal protective equipment against pesticide exposure 2015; 187: 142
    PubMedSearch in Google Scholar
  • 12 Gorecki L, Korabecny J, Musilek K, Nepovimova E, Malinak D, Kucera T. et al. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006–2016) 2017; 27: 971-985
    PubMedSearch in Google Scholar
  • 13 Worek F, Thiermann H.. The value of novel oximes for treatment of poisoning by organophosphorus compounds 2013; 139: 249-259
    PubMedSearch in Google Scholar
  • 14 de Koning MC, Horn G, Worek F, van Grol M.. Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase. 2018
    PubMedSearch in Google Scholar
  • 15 Masson P.. Novel approaches in prophylaxis/pretreatment and treatment of organophosphorus poisoning. 2016
    PubMedSearch in Google Scholar
  • 16 Katz FS, Pecic S, Tran TH, Trakht I, Schneider L, Zhu Z. et al. Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates. 2015
    PubMedSearch in Google Scholar
  • 17 Ellman GL, Courtney KD, Andres V, Featherstone RM.. A new and rapid colorimetric determination of acetylcholinesterase activity. 1961
    PubMedSearch in Google Scholar
  • 18 He F.. Bradford Protein Assay 2011; 1: e45
    PubMedSearch in Google Scholar
  • 19 Bajda M, Wiȩckowska A, Hebda M, Guzior N, Sotriffer CA, Malawska B.. Structure-Based Search for New Inhibitors of Cholinesterases 2013; 14: 5608-5632
    PubMedSearch in Google Scholar
  • 20 Herkert NM, Freude G, Kunz U, Thiermann H, Worek F.. Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase 2012; 209: 173-178
    PubMedSearch in Google Scholar
  • 21 Čolović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM.. Acetylcholinesterase Inhibitors: Pharmacology and Toxicology 2013; 11: 315
    PubMedSearch in Google Scholar
  • 22 Worek F, Thiermann Horst, Wille T.. Organophosphorus compounds and oximes: a critical review 2020; 94: 2275-2292
    PubMedSearch in Google Scholar
  • 23 De Blaquiere GE, Waters L, Blain PG, Williams FM.. Electrophysiological and biochemical effects of single and multiple doses of the organophosphate diazinon in the mouse. 2000
    PubMedSearch in Google Scholar
  • 24 Montz WE, Kirkpatrick RL.. Temporal patterns of brain cholinesterase activities of white-footed mice (Peromyscus leucopus) following dosing with diazinon or parathion 1985; 14: 19-24
    PubMedSearch in Google Scholar
  • 25 Aygun D, Doganay Z, Altintop L, Guven H, Onar M, Deniz T. et al. Serum acetylcholinesterase and prognosis of acute organophosphate poisoning 2002; 40: 903-910
    PubMedSearch in Google Scholar
  • 26 Nouira S, Abroug F, Elatrous S, Boujdaria R, Bouchoucha S.. Prognostic value of serum cholinesterase in organophosphate poisoning 1994; 106: 1811-1814
    PubMedSearch in Google Scholar
  • 27 Shih T-M, Skovira JW, O’Donnell JC, McDonough JH.. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose 2009; 19: 386-400
    PubMedSearch in Google Scholar
  • 28 dos Santos AA, dos Santos DB, Ribeiro RP, Colle D, Peres KC, Hermes J. et al. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice 2011; 32: 888-895
    PubMedSearch in Google Scholar